{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:50:54Z","timestamp":1794621054348,"version":"4.9.1"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,5,15]]},"DOI":"10.2169\/internalmedicine.1619-18","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:38:09Z","timestamp":1548974289000},"page":"1495-1499","source":"Crossref","is-referenced-by-count":6,"title":["Levofloxacin-associated Encephalopathy with Severe Hyperventilation"],"prefix":"10.2169","volume":"58","author":[{"given":"Mieko","family":"Sugiura","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University Medical Center East, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University Medical Center East, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University Medical Center East, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University Medical Center East, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Women's Medical University Medical Center East, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf 33: 353-369, 2010."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Norrby SR. Levofloxacin. Expert Opin Pharmacother 1: 109-119, 1999.","DOI":"10.1517\/14656566.1.1.109"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Carbon C. Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 47: 9-14, 2001.","DOI":"10.1159\/000057839"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology 86: 963-971, 2016.","DOI":"10.1212\/WNL.0000000000002455"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yasuda H, Yoshida A, Masuda Y, Fukayama M, Kita Y, Inamatsu T. Levofloxavin-induced neurological adverse effects such as, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients. Nihon Ronen Igakkai Zasshi 36: 213-217, 1999 (in Japanese, Abstract in English).","DOI":"10.3143\/geriatrics.36.213"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hakko E, Mete B, Ozaras R, Tabak F, Ozturk R, Mert A. Levofloxacin-induced delirium. Clin Neurol Neurosurg 107: 158-159, 2005.","DOI":"10.1016\/j.clineuro.2004.05.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moorthy N, Raghavendra N, Venkatarathnamma PN. Levofloxacin-induced acute psychosis. Indian J Psychiatry 50: 57-58, 2008.","DOI":"10.4103\/0019-5545.39762"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kiangkitiwan B, Doppalapudi A, Fonder M, Solberg K, Bohner B. Levofloxacin induced delirium with psychotic features. Gen Hosp Psychiatry 30: 381-383, 2008.","DOI":"10.1016\/j.genhosppsych.2007.11.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Slobodin G, Elias N, Zaygraikin N, et al. Levofloxacin-induced delirium. Neurol Sci 30: 159-162, 2009.","DOI":"10.1007\/s10072-009-0027-9"},{"key":"10","unstructured":"10. Kochygit I, Dortdudak S, Sipahioglu M, et al. Levofloxacin-induced delirium: is it a dangerous drug in patients with renal dysfunction. Ren Fail 34: 634-636, 2012."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Raj V, Murthy TV. Levofloxacin induced delirium with psychotic features in a young patient. Med J Armed Forces India 69: 404-405, 2013.","DOI":"10.1016\/j.mjafi.2012.10.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lertxundi U, Palacios RH, Gutierrez FC, Domingo-Echaburu S, Garcia MG, Gomez CA. Levofloxacin-induced delirium in a patient suffering from schizoaffective disorder and multiple sclerosis. Curr Drug Saf 8: 199-200, 2013.","DOI":"10.2174\/15748863113089990043"},{"key":"13","unstructured":"13. Singh D, Kapoor A, Singhal MK, Singh V, Kumar HS. Levofloxacin induced psychosis: a rare case report. Int J Basic Clin Pharmacol 3: 726-728, 2014."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ghoshal A, Damani A, Salins N, Deodhar J, Muckaden MA. Management of levofloxacin induced anaphylaxis and acute delirium in a palliative care setting. Indian J Palliat Care 21: 76-78, 2015.","DOI":"10.4103\/0973-1075.150194"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takser L, Grad R. Acute psychotic symptoms following a single dose of levofloxacin. Clin Case Rep 5: 2136-2137, 2017.","DOI":"10.1002\/ccr3.1240"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. North DS, Fish DN, Redington JJ. Levofloxacin, a second-generation fluoroquinolone. Pharmacotherapy 18: 915-935, 1998.","DOI":"10.1002\/j.1875-9114.1998.tb03925.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly. An update. Drugs Aging 27: 193-209, 2010.","DOI":"10.2165\/11531490-000000000-00000"},{"key":"18","unstructured":"18. Hori S, Shimada J. Effects of quinolones on the central nervous system. In: Quinolone Antimicrobial Agents. 2nd ed. Hooper DC, Wolfson JS, Eds. American Society for Microbiology, Washington DC, 1993: 513-518."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. McGuire P, Allen P, Howes O, et al. GABA interneuron dysfunction and the onset of psychosis. Schizophr Bull 43: S3-S4, 2017.","DOI":"10.1093\/schbul\/sbx021.010"},{"key":"20","unstructured":"20. Tarulli AW, Lim C, Bui JD, Saper CB, Alexander MP. Central neurogenic hyperventilation: a case report and discussion of pathophysiology. Arch Neurol 62: 1632-1634, 2005."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vural A, Arsava MA, Dericioglu N, Topcuoglu MA. Central neurogenic hyperventilation in Anti-NMDA receptor encephalitis. Intern Med 51: 2789-2792, 2012.","DOI":"10.2169\/internalmedicine.51.8215"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ikeguchi R, Shibuya K, Akiyama S, et al. Rituximab used successfully in the treatment of Anti-NMDA receptor encephalitis. Intern Med 51: 1585-1589, 2012.","DOI":"10.2169\/internalmedicine.51.6874"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10: 63-74, 2011.","DOI":"10.1016\/S1474-4422(10)70253-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Waters KA, Machaalani R. Role of NMDA receptors in development of respiratory control. Respir Physiol Neurobiol 149: 123-130, 2005.","DOI":"10.1016\/j.resp.2005.03.009"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/10\/58_1619-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:17:44Z","timestamp":1720963064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/10\/58_1619-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1619-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]}}}